Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia in Lung Cancer Management: A Translational Approach
Julien Ancel, Jeanne‐Marie Perotin, Maxime Dewolf, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3421-3421
Open Access | Times Cited: 24

Showing 24 citing articles:

Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors
Julien Ancel, Valérian Dormoy, Béatrice Nawrocki‐Raby, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy
Mark W. Dewhirst, James R. Oleson, John P. Kirkpatrick, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1701-1701
Open Access | Times Cited: 20
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
Juan Bautista De Sanctis, Jaime Charris, Zuleyma Blanco, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 10, pp. 1122-1144
Closed Access | Times Cited: 19
A Pilot Study on Qualitative Metabolomics to Characterize Lewis Lung Carcinoma in Mice
Agnieszka Stawarska, Magdalena Bamburowicz‐Klimkowska, Dariusz Maciej Pisklak, et al.
Life (2025) Vol. 15, Iss. 2, pp. 202-202
Open Access
Identification of IGF2BPs-related mRNA signature for predicting the overall survival of lung adenocarcinoma
Xiang Xu, Weidi Zhao, Di Peng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Recapitulating Tumor Hypoxia in a Cleanroom-Free, Liquid-Pinning-Based Microfluidic Tumor Model
Jeong Min Oh, Hydari Masuma Begum, Yao Lucia Liu, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 7, pp. 3107-3121
Open Access | Times Cited: 15
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Nerea Otegui, Maeva Houry, Imanol Arozarena, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 8
Single-cell data analysis of malignant epithelial cell heterogeneity in lung adenocarcinoma for patient classification and prognosis prediction
Ran Xu, Tong Lu, Chenghao Wang, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20164-e20164
Open Access | Times Cited: 8
Molecular Pathways and Key Genes Associated With Breast Width and Protein Content in White Striping and Wooden Breast Chicken Pectoral Muscle
Martina Bordini, Francesca Soglia, R. Davoli, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
Bodong Zhou, Wenbo Zhu, Shuai Yuan, et al.
Thoracic Cancer (2021) Vol. 13, Iss. 3, pp. 369-379
Open Access | Times Cited: 16
Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures
Irena Wieleba, Kamila Wojas‐Krawczyk, Paweł Krawczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2261-2261
Open Access | Times Cited: 9
A Role of Non-FDG Tracers in Lung Cancer?
Emil Novruzov, Yuriko Mori, Christina Antke, et al.
Seminars in Nuclear Medicine (2022) Vol. 52, Iss. 6, pp. 720-733
Closed Access | Times Cited: 9
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies
Emma Loeffler, Julien Ancel, Véronique Dalstein, et al.
Life (2023) Vol. 14, Iss. 1, pp. 64-64
Open Access | Times Cited: 5
A deformability-based biochip for precise label-free stratification of metastatic subtypes using deep learning
Haojun Hua, Shangjie Zou, Zhiqiang Ma, et al.
Microsystems & Nanoengineering (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Hypoxia A Typical Target in Human Lung Cancer Therapy
Asmat Ullah, Somia Shehzadi, Najeeb Ullah, et al.
Current Protein and Peptide Science (2023) Vol. 25, Iss. 5, pp. 376-385
Closed Access | Times Cited: 4
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Jérôme Levallet, Tiphaine Biojout, Céline Bazille, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 4
Prognostic Significance of Potential Target Networks and P16INK4a In Early Diagnosis of Non-Small Cell Lung Cancer
Varnika Kundadka, Radha Vatsa, Navrinder Kaur
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Targeting the lung tumor stroma: harnessing nanoparticles for effective therapeutic interventions
Shushu Zhang, Hui Wang
Journal of drug targeting (2024) Vol. 33, Iss. 1, pp. 60-86
Closed Access | Times Cited: 1
Programmed death ligand-1 expression and its association with the degree of differentiation and the presence of necrosis in non-small cell lung carcinoma
Alžbeta Blichárová, Vladimír Tancoš, Zuzana Benetinová, et al.
Pathology - Research and Practice (2023) Vol. 242, pp. 154296-154296
Closed Access | Times Cited: 3
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer
Tingting Jia, Ruoyang Miao, Jiankang Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 91, pp. 117384-117384
Closed Access | Times Cited: 3
Treatment Response Biomarkers: Working Toward Personalized Radiotherapy for Lung Cancer
Ashley Horne, Ken Harada, Katherine D. Brown, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1164-1185
Open Access
Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma
Hongliang Hui, Dan Li, Yangui Lin, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 7, pp. 3919-3933
Open Access | Times Cited: 1
A New Hypoxia-Related Prognostic Risk Score (HPRS) Model Was Developed to Indicate Prognosis and Response to Immunotherapy for Lung Adenocarcinoma
Xiahui Yang, Minchao Liang, Zhiqi Yu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 1
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Jérôme Levallet, Tiphaine Biojout, Céline Bazille, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top